ATE135211T1 - 5-aryl-4-alkyl-3h-1,2,4-triazol-3-thione zur verbesserung des gedächtnisses - Google Patents

5-aryl-4-alkyl-3h-1,2,4-triazol-3-thione zur verbesserung des gedächtnisses

Info

Publication number
ATE135211T1
ATE135211T1 AT91106219T AT91106219T ATE135211T1 AT E135211 T1 ATE135211 T1 AT E135211T1 AT 91106219 T AT91106219 T AT 91106219T AT 91106219 T AT91106219 T AT 91106219T AT E135211 T1 ATE135211 T1 AT E135211T1
Authority
AT
Austria
Prior art keywords
alkyl
triazole
thione
aryl
improve memory
Prior art date
Application number
AT91106219T
Other languages
English (en)
Inventor
Jerry A Miller
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Application granted granted Critical
Publication of ATE135211T1 publication Critical patent/ATE135211T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT91106219T 1990-04-19 1991-04-18 5-aryl-4-alkyl-3h-1,2,4-triazol-3-thione zur verbesserung des gedächtnisses ATE135211T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51352490A 1990-04-19 1990-04-19
US07/658,789 US5100906A (en) 1990-04-19 1991-02-26 5-aryl-4-alkyl-3h-1,2,4-triazole-3-thiones useful as memory enhancers

Publications (1)

Publication Number Publication Date
ATE135211T1 true ATE135211T1 (de) 1996-03-15

Family

ID=27057902

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91106219T ATE135211T1 (de) 1990-04-19 1991-04-18 5-aryl-4-alkyl-3h-1,2,4-triazol-3-thione zur verbesserung des gedächtnisses

Country Status (9)

Country Link
US (1) US5100906A (de)
EP (1) EP0452926B1 (de)
JP (1) JP3015495B2 (de)
KR (1) KR0180935B1 (de)
AT (1) ATE135211T1 (de)
AU (1) AU631982B2 (de)
DE (1) DE69117791T2 (de)
DK (1) DK0452926T3 (de)
IE (1) IE71917B1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250558A (en) * 1992-01-28 1993-10-05 Merck & Co., Inc. Substituted triazolinones, triazolinethiones, and triazolinimines as neurotensin antagonists used to treat psychosis
NZ275620A (en) * 1993-10-29 1999-01-28 Merrell Pharma Inc 3-optionally substituted phenyl or naphthyl-1,2,4-triazole derivatives; pharmaceutical compositions
US5489598A (en) * 1994-06-08 1996-02-06 Warner-Lambert Company Cytoprotection utilizing aryltriazol-3-thiones
AR039385A1 (es) 2002-04-19 2005-02-16 Astrazeneca Ab Derivados de tioxantina como inhibidores de la mieloperoxidasa
SE0301232D0 (sv) * 2003-04-25 2003-04-25 Astrazeneca Ab Novel use
SE0402591D0 (sv) * 2004-10-25 2004-10-25 Astrazeneca Ab Novel use
MY140748A (en) 2004-12-06 2010-01-15 Astrazeneca Ab Novel pyrrolo [3,2-d] pyrimidin-4-one derivatives and their use in therapy
TW200804383A (en) 2006-06-05 2008-01-16 Astrazeneca Ab New compounds
CN105218465A (zh) * 2015-11-14 2016-01-06 刘杰 一种治疗乳腺癌的药物组合物
WO2023080555A1 (ko) 2021-11-02 2023-05-11 엘지전자 주식회사 옷걸이 및 옷걸이가 구비된 의류처리장치

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3439450A1 (de) * 1984-10-27 1986-05-07 Boehringer Ingelheim KG, 6507 Ingelheim 1,2,4-triazolo-carbamate und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel
US4912095A (en) * 1985-10-29 1990-03-27 Merrell Dow Pharmaceuticals Inc. 5-aryl-2,4-dialkyl-3H-1,2,4-triazole-3-thiones useful as antidepressants
US4775688A (en) * 1985-12-11 1988-10-04 Merrell Dow Pharmaceuticals Inc. 5-aryl-2,4-dialkyl-3H-1,2,4-triazole-3-thiones and their use as antidepressants
EP0280867A1 (de) * 1987-01-27 1988-09-07 Merrell Dow Pharmaceuticals Inc. Verfahren zur Herstellung von 5-aryl-2,4-dialkyl-3H-1,2,4-triazol-3-thione
US4847276A (en) * 1988-09-06 1989-07-11 Merrell Dow Pharmaceuticals Inc. Treatment of thromobocytosis with 5-(4-chlorophenyl)-2,4-diemthyl-3H-1,2,4-triazole-3-thione

Also Published As

Publication number Publication date
JP3015495B2 (ja) 2000-03-06
DE69117791T2 (de) 1996-08-01
DE69117791D1 (de) 1996-04-18
EP0452926A2 (de) 1991-10-23
DK0452926T3 (da) 1996-04-01
AU631982B2 (en) 1992-12-10
EP0452926B1 (de) 1996-03-13
AU7437891A (en) 1991-10-24
EP0452926A3 (en) 1992-05-06
US5100906A (en) 1992-03-31
JPH04225917A (ja) 1992-08-14
KR0180935B1 (ko) 1999-04-01
IE911304A1 (en) 1991-10-23
KR910018023A (ko) 1991-11-30
IE71917B1 (en) 1997-03-12

Similar Documents

Publication Publication Date Title
DK441187D0 (da) Alfa-alkyl-4-amino-3-quinolinmethanoler og 1-(4-aralkylamino-3-quinolinyl)alkanoner, deres fremstilling og anvendelse
SE7909392L (sv) Nya substituerade 5-(2-imidazolin-2-yl)-aminopyrimidiner
FI931370A0 (fi) Kvaeve innehaollande analoger av icke-aromatiska heterocykliska foereningar med en fusionerad ring
PT88603A (pt) Immunomodulatory azapiranes
FI925595A0 (fi) Piperazinyl- och piperidinylcyklohexanolfoereningar
ATE154355T1 (de) Hydantoinverbindungen
GR3019468T3 (en) 4- and 6-Carbamates related to physostigmine, a process and intermediates for their preparation and their use as medicaments
NO942610L (no) Heterosykliske forbindelser og deres fremstilling og anvendelse
ATE135211T1 (de) 5-aryl-4-alkyl-3h-1,2,4-triazol-3-thione zur verbesserung des gedächtnisses
ATE79257T1 (de) Verwendung von tetrahydrobenz(c,d>indol-6carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden.
NO874872L (no) Kondenderte heterocykliske tetrahydroaminokinolinoler og beslektede forbindelser samt fremgangsmaate for fremstilling derav.
DE69005984D1 (de) 2-Hydroxy-3-phenoxypropylaminoverbindungen.
DK325188D0 (da) Hidtil ukendte benzazepinderivater
ATE71620T1 (de) N-substituierte 3,4-dihydropyrimidinverbindungen als mittel zur behandlung von erkrankungen des kardiovaskularen systems.
NO895222L (no) Fremgangsmaate for fremstilling av n-pyridinyl-9h-karbazol-9-aminer.
NO914192L (no) 8-azabicyklo(3.2.1)oktylalkylthiazolidinoner, fremgangsmaate for fremstilling og anvendelse som medikamenter
FI96307C (fi) Menetelmä terapeuttisesti käyttökelpoisen (1,2,3,4-tetrahydro-9-akridiini-imino)sykloheksaanikarboksyylihapon ja sen johdannaisten valmistamiseksi
ATE283269T1 (de) 5-(heteroaryl)alkyl)-3-oxo-pyrido(1,2- a)benzimidazol-4-carboxamid (pbi) derivate zur behandlung von störungen des zentralen nervensystems
FI902851A0 (fi) 4,5,5a,6-tetrahydro-3h-isoxazolo/5,4,3 -kl/akridinderivat, foerfarande foer deras framstaellande och deras anvaendning som laekemedel.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee